Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Cardioversion of atrial fibrillation or flutter to sinus rhythm using ibutilide is more successful and less likely to trigger torsades de pointes when…
NEW YORK (Reuters Health) – Epileptic seizures in children can be terminated at home just as well with intranasal midazolam as with rectal diazepam, a comparison study shows.…
NEW YORK (Reuters Health) – For children with type 1 diabetes being treated with an insulin pump, lowering the basal insulin rate after exercise reduces the occurrence of…
NEW YORK (Reuters Health) – There appears to be no increase or decrease in mortality among arthritis patients treated with anti-tumor necrosis factor agents, when compared to standard…
NEW YORK (Reuters Health) – Outcomes of percutaneous coronary intervention are just as good when a loading dose of clopidogrel is given in the cath lab just before…
NEW YORK (Reuters Health) – Revised guidelines on the prevention and treatment of osteoporosis related to glucocorticoid use recommend bisphosphonate therapy but withdraw endorsement of testosterone and estrogen…
NEW YORK (Reuters Health) – Among patients hospitalized for methicillin-resistant Staphylococcus aureus infection, treatment with linezolid is as effective as “gold standard” treatment with vancomycin. In fact, length…
NEW YORK (Reuters Health) – The safety and efficacy of intensive statin therapy initiated soon after a first MI are maintained at 5 years, Scandinavian investigators report. They…
NEW YORK (Reuters Health) – Prospective study results suggest that saquinavir is the only older protease inhibitor (PI) not associated with an increased risk of myocardial infarction (MI).…
NEW YORK (Reuters Health) – When kids have asthma symptoms on moderate doses of inhaled corticosteroids (ICS), adding a long-acting beta-agonist (LABA) achieves the same effect as doubling…
